Metastatic Malignant Neoplasm in the Brain Clinical Trials
2 recruiting trials for Metastatic Malignant Neoplasm in the Brain. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Metastatic Malignant Neoplasm in the Brain clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 3 (2 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by M.D. Anderson Cancer Center (1), NRG Oncology (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Stereotactic Radiosurgery (radiation, 2 trials), followed by Quality-of-Life Assessment, Questionnaire Administration.
Track Metastatic Malignant Neoplasm in the Brain trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
This phase III trial studies stereotactic radiosurgery (SRS) before surgery to see how well it works compared with SRS after surgery in treating patients with cancer that has...
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the...
This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Metastatic Malignant Neoplasm in the Brain, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Metastatic Malignant Neoplasm in the Brain, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 2 Phase 3 trials for Metastatic Malignant Neoplasm in the Brain, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.